Hertz Expands Program Allowing Prolonged 3-Day Test Drives Before Vehicle Purchase To Over 100 Cities

Published : Aug 14, 2025, 08:20 PM IST
https://stocktwits.com/news-articles/markets/equity/hertz-expands-program-allowing-prolonged-3-day-test-drives-before-vehicle-purchase-to-over-100-cities/chsRlcNRdOh

Synopsis

Consumers can test the vehicles for up to three days before purchasing at a low daily rate.

Car rental firm Hertz Global Holdings Inc. (HTZ) on Thursday announced the expansion of its Rent2Buy program to over 100 cities.

The program offers thousands of used vehicles, including newly added 2025 models, for an extended test drive. Consumers can test the vehicles for up to three days at a low daily rate before purchasing. Further, if they decide to purchase the vehicle, the rental fee would be waived, the company added.

On Stocktwits, retail sentiment around Hertz fell from ‘bullish’ to ‘bearish’ territory over the past 24 hours, while message volume fell from ‘high’ to ‘low’ levels. HTZ stock traded 2% lower at the time of writing.

Under the Rent2Buy program, consumers can reserve a vehicle after browsing online and either take a 2-hour test drive or rent it for up to 3 days. If the customer likes the car, they can buy it. Every Rent2Buy vehicle is backed by a 12-month/12,000-mile limited powertrain warranty, whichever comes first, 24-hour roadside assistance, travel breakdown protection, and a 7-day/250-mile buy-back guarantee.

Currently, several 2025 model year vehicles are listed on the Hertz car sales website under the Rent2Buy program, including the Nissan Altima, Toyota Camry, Jeep Compass, Volkswagen Jetta, Hyundai Palisade, and the Chevrolet Equinox. The cheapest 2025 model year available to purchase on the site under the program is currently the Nissan Sentra S sedan, starting at about $15,000, while the most expensive is the Chevrolet Express Cargo van priced at about $50,000.

Vehicles on the site range from commuter cars, family SUVs, and luxury rides.

HTZ stock is up by 44% this year and by 60% over the past 12 months. 

Read also: Aquestive Therapeutics Stock Is Rising Pre-Market – Its $75M Funding Agreement Draws Divided Opinions From Retail

For updates and corrections, email newsroom[at]stocktwits[dot]com.<

PREV

Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.

Recommended Stories

Bruce Campbell's Top Picks: Anaergia, Tantalus Systems & Happy Belly Food
Cytokinetics Wins First FDA Approval For Heart Disease Drug — Why Is Wall Street Still Cautious?